Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some studies. Different strategies to reduce RAO include the use of small caliber catheters, adequate anticoagulation and punction site care after procedure. 

¿Es útil el uso de vasodilatadores intra-arteriales para prevenir la oclusión de la arteria radial?

Vasodilators are used to prevent radial spasm during procedure. However, using it after procedure should increase flow, improving hemostasis, and preventing RAO. 

The aim of this prospective, multicenter, randomized, double blind study was to assess whether the administration of nitroglycerin at the beginning or at the end of procedure might preserve radial artery patency compared against placebo. 

Primary end point was early RAO incidence confirmed by ultrasound up to 24 hrs. after procedure. Secondary end point was late RAO (30 days after procedure). 

It included 2040 patients. Mean age was 61 and 38% were women. The right radial artery was the most used (99.9%), and catheterization was the most frequent diagnostic procedure. 

Read also: Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome

There were no significant differences when looking at primary and secondary end points. The presence of recanalization at 30 days assessed by Doppler was 30% with no differences between the groups.  

At multivariable analysis, the presence of radial spasm and access achieved with more than one puncture attempt were independent predictors of RAO at 24 hrs. 

Conclusion

The use of nitroglycerin was not associated with reduced RAO rate, regardless of time of administration, and therefore it should not be considered mandatory to prevent this complication. 

Dr. Andrés Rodríguez.
Member of the Editorial Board in SOLACI.org .

Original Title: Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin PATENS Trial.

Reference: Roberto L. da Silva, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...